Pediatric arterial ischemic stroke in Japan: Moyamoya disease or not
Pediatric arterial ischemic stroke in Japan: Moyamoya disease or not
复制标题
日本小儿动脉缺血性中风:烟雾病与否
DOI:
10.1016/j.jstrokecerebrovasdis.2023.107063
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Mori N.
中科院分区:
文献类型:
--
作者:
Mugikura S;Mori N.
Dear Editor: We read with great interest the article by Scoville J et al. that surveyed children's hospitals belonging to the Children’s Hospital Association to determine the consensus regarding the diagnostic and treatment protocols for pediatric arterial ischemic stroke (AIS). 1 In this study, among 93 responders from physicians in 50 pediatric hospitals, consensus agreement, being available to treat pediatric AIS, was 90.3% in the use of intravenous tissue plasminogen activator (tPA) and 77.4% in mechanical thrombectomy. This result piqued our interest in the current state of management for pediatric AIS in Japan and in discussing the state from the epidemiological perspective that moyamoya disease is the leading cause of pediatric AIS in Japan.A recent survey of 40 children residing in the Aichi Prefecture of Japan with radiologically confirmed AIS between 2010 and 2014 suggested that the long in-hospital delays are associated with the diagnosis of pediatric AIS, likely due to a lack of awareness of AIS by physicians. 2 The 26 children with AIS, in whom time to diagnosis was analyzed, included eight children with moyamoya disease, five with cardiac disease, eight with unknown causes. In this study, the median time from symptom onset to confirmed AIS diagnosis was 27.0 h and intravenous tPA and mechanical thrombectomy were not performed in any patient. We completely agree with their conclusion that further efforts to increase public and physician awareness of pediatric AIS are needed to ensure the early recognition, diagnosis, and treatment of pediatric AIS.